ArticleFrontiers in neurology2025
Development and validation of explainable machine learning models for predicting 3-month functional outcomes in acute ischemic stroke: a SHAP-based approach.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predicting early neurological deterioration in acute branch atheromatous disease without reperfusion therapy: a machine learning model.Frontiers in neuroscience · 2026Article
- Machine learning-based prediction model for cognitive frailty in elderly patients with ischaemic stroke: a prospective cohort study.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate explainable machine learning models for predicting 3-month functional outcomes in acute ischemic stroke (AIS) patients using SHapley Additive exPlanations (SHAP) framework. Methods: This retrospective cohort study included 538 AIS patients admitted within 72 h of symptom onset. Patients were randomly divided into training (70%) and validation (30%) sets. Clinical, laboratory, and imaging data were collected. Least Absolute Shrinkage and Selection Operator regression was used for feature selection. Five machine learning models were developed: support vector machine, Results: Among 538 patients (mean age 68.5 ± 12.7 years, 58.0% male), 34.2% had poor 3-month outcomes (mRS 3-6). The GBM achieved the best predictive performance with AUC of 0.91, accuracy of 0.81, sensitivity of 0.95, and specificity of 0.61 in validation set, significantly outperforming logistic regression (AUC = 0.78). The model demonstrated excellent calibration and superior net benefit in decision curve analysis across threshold probabilities of 0.1-0.7. SHAP analysis identified admission NIHSS score (30.8%), age (14.9%), and ASPECTS ≥7 (13.7%) as the most influential predictors, with neutrophil-to-lymphocyte ratio (10.1%) and platelet distribution width (9.7%) also contributing significantly to outcome prediction. Conclusion: Explainable machine learning models can accurately predict 3-month functional outcomes in AIS patients. The SHAP framework enhances model transparency, addressing interpretability barriers for clinical implementation while maintaining superior predictive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.